Is this you? Create Your Porfile
Avatar

Fatima Emitsel Yakubu-Madus

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Fatima Emitsel Yakubu-Madus is active.

Explore More

Publication

Featured researches published by Fatima Emitsel Yakubu-Madus.

Archive | 2000

Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagon-like peptide-1 and agonists thereof

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Vignati Louis

Archive | 2003

Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Archive | 2000

Synergetic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependant diabetes

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Archive | 2000

Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Archive | 2000

Utilisation combinee de thiazolidinediones et de peptide-1 de type glucagone et d'agonistes de ces derniers pour traiter l'instabilite metabolique associee aux diabetes non insulino-dependants.

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Archive | 2000

Synergitische verwendung von thiazolidinedionen und glucagon-ähnlichem peptid-1 und dessen agonisten für die behandlung von nicht-insulin-abhängigen diabetes

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Archive | 2000

Synergitische verwendung von thiazolidinedionen und glucagon-ähnlichem peptid-1 und dessen agonisten für die behandlung von nicht-insulin-abhängigen diabetes Synergitische use of thiazolidinediones and glucagon-like peptide-1 and its agonists for the treatment of non-insulin-dependent diabetes

William T. Johnson; Lawrence E. Stramm; Louis Vignati; Fatima Emitsel Yakubu-Madus

Archive | 2000

Utilisation synergique des thiazolidinediones avec peptide-1 comme glucagon et agonistes correspondants pour traiter les diabètes non dépendants de l'insuline

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Archive | 2000

Synergitische use of thiazolidinediones and glucagon-like peptide-1 and its agonists for the treatment of non-insulin-dependent diabetes

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Archive | 2000

Synergistische Verwendung von Thiazolidindionen mit glucagonartigem Peptid-1 und Agonisten davon zur Behandlung von nicht insulinabhängigen Diabetes

Fatima Emitsel Yakubu-Madus; Lawrence E. Stramm; William T. Johnson; Louis Vignati

Explore More

Collaboration

Dive into the Fatima Emitsel Yakubu-Madus's collaboration.

Top Co-Authors
Avatar

Lawrence E. Stramm

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

William T. Johnson

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Louis Vignati

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Vignati Louis

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge